# The First Affiliated Hospital of Guangzhou Medical University

Organization · id `cardio:org-the-first-affiliated-hospital-of-guangzhou-medical-cf91d6` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov sponsor names](<https://clinicaltrials.gov/search?spons=The+First+Affiliated+Hospital+of+Guangzhou+Medical+University>), retrieved 18 November 2026. No person wrote or checked this page.

## In plain language

An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 4 trials in this atlas.

## Technical summary

Sponsor class other. No ROR record matches the name exactly.

## The registry's words

- Sponsor name: The First Affiliated Hospital of Guangzhou Medical University
- Sponsor class: OTHER

## Connected pages

- Sponsors: Evaluation of WATCHMAN Left Atrial Appendage Occlusion Device in Patients With Atrial Fibrillation Versus Rivaroxaban (`cardio:ct-nct02549963`)
- Sponsors: A Trial to Evaluate the Safety and Efficacy of Pulmonary Artery Denervation for the Treatment of Pulmonary Hypertension Associated With Left Heart Failure (`cardio:ct-nct05824923`)
- Sponsors: Efficacy and Safety of Methylprednisolone After Flow-Diverter Stent Implantation in Unruptured Intracranial Aneurysms (`cardio:ct-nct07353749`)
- Sponsors: Study on the Safety and Efficacy of a Time-of-Day-Based Individualized Tacrolimus Dosing Regimen in Kidney Transplant Recipients (`cardio:ct-nct07877103`)

## Provenance

Content hash: c3ec6d26b29d3e785d172670aaf0c2e00faca67ddf047cfa9e00c17693417d0b
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
